{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:11:45Z","timestamp":1791486705712,"version":"4.3.4"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroToxicology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.neuro.2025.103350","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T10:24:22Z","timestamp":1763029462000},"page":"103350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Blockade of NMDA-receptors mitigates autistic and cognitive behaviors via modulation of TLR-4\/NLRP3 inflammasomes and microglia\/astrocyte crosstalk in rat model of autism"],"prefix":"10.1016","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8295-5163","authenticated-orcid":false,"given":"Sawsan","family":"Aboul-Fotouh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohir M.","family":"Zohny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada AM.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer M.","family":"Eissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba Hamed","family":"Elshahawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar M.","family":"Abdelraouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manar Yehia","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed R.","family":"Rabei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma E.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Nageh","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman H.","family":"Eltantawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaimaa","family":"khedr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin","family":"Ramadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha Khaled","family":"El-Ashry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esraa M.","family":"Elnahas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuro.2025.103350_bib1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.pbb.2012.12.027","article-title":"Coenzyme Q10 displays antidepressant-like activity with reduction of hippocampal oxidative\/nitrosative DNA damage in chronically stressed rats","volume":"104","author":"Aboul-Fotouh","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuro.2025.103350_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2025.106019","article-title":"Can memantine treat autism? Answers from preclinical and clinical studies","volume":"169","author":"Aboul-Fotouh","year":"2025","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"2","key":"10.1016\/j.neuro.2025.103350_bib3","article-title":"Dysregulation of Ki-67 expression in T cells of children with autism spectrum disorder","volume":"8","author":"Alhosaini","year":"2021","journal-title":"Children (Basel, Switzerland)"},{"issue":"1","key":"10.1016\/j.neuro.2025.103350_bib4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/jnr.22172","article-title":"Memantine lowers amyloid-beta peptide levels in neuronal cultures and in APP\/PS1 transgenic mice","volume":"88","author":"Alley","year":"2010","journal-title":"J. Neurosci. Res."},{"issue":"5","key":"10.1016\/j.neuro.2025.103350_bib5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1089\/cap.2015.0146","article-title":"Safety and efficacy of memantine in children with autism: randomized, placebo-controlled study and open-label extension","volume":"27","author":"Aman","year":"2017","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.neuro.2025.103350_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2025.111503","article-title":"Cognitive and psychotic effects of ketamine \"short- vs. long-term\" therapy in a rat model of depression: hippocampal TrkB\/Akt\/GSK-3beta\/mTOR\/autophagy trajectories","author":"Aref","year":"2025","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.neuro.2025.103350_bib7","first-page":"1","article-title":"Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2014","volume":"67","author":"Baio","year":"2018","journal-title":"Morb. Mortal. Wkly. Report. Surveill. Summ. (Washington, D.C.: 2002)"},{"key":"10.1016\/j.neuro.2025.103350_bib8","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4103\/apjtb.apjtb_937_23","article-title":"Neuroprotective effect of liraglutide and memantine in a rat model of Alzheimer\u2019s disease","volume":"14","author":"Bakhshwin","year":"2024","journal-title":"Asian Pac. J. Trop. Biomed."},{"issue":"3","key":"10.1016\/j.neuro.2025.103350_bib9","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/jnc.15501","article-title":"Criss-crossing autism spectrum disorder and adult neurogenesis","volume":"159","author":"Bicker","year":"2021","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuro.2025.103350_bib10","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"issue":"8","key":"10.1016\/j.neuro.2025.103350_bib11","first-page":"CD013845","article-title":"Memantine for autism spectrum disorder","volume":"8","author":"Brignell","year":"2022","journal-title":"Cochrane Database Syst. Rev."},{"issue":"10","key":"10.1016\/j.neuro.2025.103350_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111771","article-title":"NMDA receptor hypofunction underlies deficits in parvalbumin interneurons and social behavior in neuroligin 3 R451C knockin mice","volume":"41","author":"Cao","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuro.2025.103350_bib13","unstructured":"CDC, 2025. Centers for Disease Control and Prevention (CDC) (2025). Data and Statistics on Autism Spectrum Disorder. Available at \u3008https:\/\/www.cdc.gov\/autism\/data-research\/index.html\u3009 [Accessed at: May 28, 2025]."},{"key":"10.1016\/j.neuro.2025.103350_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2021.736003","article-title":"Pharmacological neurorescue in a paclitaxel-induced chemobrain model","volume":"15","author":"Chen","year":"2021","journal-title":"Front. Behav. Neurosci."},{"issue":"5","key":"10.1016\/j.neuro.2025.103350_bib15","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1177\/0883073807302611","article-title":"Memantine as adjunctive therapy in children diagnosed with autistic spectrum disorders: an observation of initial clinical response and maintenance tolerability","volume":"22","author":"Chez","year":"2007","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.neuro.2025.103350_bib16","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.euroneuro.2021.10.049","article-title":"P.0044 Memantine improves social behavior in rats exposed prenatally to valproic acid","volume":"53","author":"Chighladze","year":"2021","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"5","key":"10.1016\/j.neuro.2025.103350_bib17","doi-asserted-by":"crossref","first-page":"238","DOI":"10.5483\/BMBRep.2022.55.5.038","article-title":"Autistic-like social deficits in hippocampal MeCP2 knockdown rat models are rescued by ketamine","volume":"55","author":"Choi","year":"2022","journal-title":"BMB Rep."},{"issue":"7","key":"10.1016\/j.neuro.2025.103350_bib18","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.biopsych.2018.09.025","article-title":"Early correction of N-methyl-D-aspartate receptor function improves autistic-like social behaviors in adult shank2(-\/-) mice","volume":"85","author":"Chung","year":"2019","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.neuro.2025.103350_bib19","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nn.3927","article-title":"Social deficits in IRSp53 mutant mice improved by NMDAR and mGluR5 suppression","volume":"18","author":"Chung","year":"2015","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.neuro.2025.103350_bib20","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41380-018-0056-y","article-title":"The ASD living biology: from cell proliferation to clinical phenotype","volume":"24","author":"Courchesne","year":"2019","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"10.1016\/j.neuro.2025.103350_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/biom14040437","article-title":"Roles of epigenetics and glial cells in drug-induced autism spectrum disorder","volume":"14","author":"Csoka","year":"2024","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.neuro.2025.103350_bib22","first-page":"1323","article-title":"2018. Direct binding of Toll-like receptor 4 to ionotropic glutamate receptor N-methyl-D-aspartate subunit 1 induced by lipopolysaccharide in microglial cells N9 and EOC 20","volume":"41","author":"Cui","year":"2017","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.neuro.2025.103350_bib23","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/nprot.2006.20","article-title":"Digging and marble burying in mice: simple methods for in vivo identification of biological impacts","volume":"1","author":"Deacon","year":"2006","journal-title":"Nat. Protoc."},{"issue":"2","key":"10.1016\/j.neuro.2025.103350_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/biom12020181","article-title":"Targeted NMDA receptor interventions for autism: developmentally determined expression of GluN2B and GluN2A-containing receptors and balanced allosteric modulatory approaches","volume":"12","author":"Deutsch","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.neuro.2025.103350_bib25","series-title":"Diagnostic and Statistical Manual of Mental Disorders","article-title":"Diagnostic and statistical manual of mental disorders","author":"DSM-5","year":"2013"},{"key":"10.1016\/j.neuro.2025.103350_bib26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neuro.2020.12.016","article-title":"Cognitive effects of the GSK-3 inhibitor \"lithium\" in LPS\/chronic mild stress rat model of depression: hippocampal and cortical neuroinflammation and tauopathy","volume":"83","author":"Ebeid","year":"2021","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuro.2025.103350_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.110185","article-title":"Validation of prenatal versus postnatal valproic acid rat models of autism: a behavioral and neurobiological study","volume":"108","author":"Elnahas","year":"2021","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuro.2025.103350_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2022.110522","article-title":"Novel role of peroxisome proliferator activated receptor-alpha in valproic acid rat model of autism: Mechanistic study of risperidone and metformin monotherapy versus combination","volume":"116","author":"Elnahas","year":"2022","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.neuro.2025.103350_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/hup.2841","article-title":"Evaluation of memantine's efficacy and safety in the treatment of children with autism spectrum disorder: a systematic review and meta-analysis","volume":"37","author":"Elnaiem","year":"2022","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.neuro.2025.103350_bib30","article-title":"Memantine mitigates ROS\/TXNIP\/NLRP3 signaling and protects against mouse diabetic retinopathy: Histopathologic, ultrastructural and bioinformatic studies","volume":"163","author":"ElSayed","year":"2023","journal-title":"Biomed. Pharmacother. = Biomedecine Pharmacother."},{"key":"10.1016\/j.neuro.2025.103350_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1160967","article-title":"Intraneuronal accumulation of amyloid-beta peptides as the pathomechanism linking autism and its co-morbidities: epilepsy and self-injurious behavior - the hypothesis","volume":"16","author":"Frackowiak","year":"2023","journal-title":"Front. Mol. Neurosci."},{"issue":"2","key":"10.1016\/j.neuro.2025.103350_bib32","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nrneurol.2016.6","article-title":"Alzheimer disease: Blocking microglial proliferation halts Alzheimer disease in mice","volume":"12","author":"Fyfe","year":"2016","journal-title":"Nat. Rev. Neurol."},{"issue":"6","key":"10.1016\/j.neuro.2025.103350_bib33","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/j.1601-183X.2012.00816.x","article-title":"Mice with reduced NMDA receptor expression: more consistent with autism than schizophrenia?","volume":"11","author":"Gandal","year":"2012","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.neuro.2025.103350_bib34","article-title":"Neural mechanisms underlying repetitive behaviors in rodent models of autism spectrum disorders","volume":"14","author":"Gandhi","year":"2020","journal-title":"Front. Cell Neurosci."},{"issue":"6","key":"10.1016\/j.neuro.2025.103350_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22063209","article-title":"Alterations in tau protein level and phosphorylation state in the brain of the autistic-like rats induced by prenatal exposure to valproic acid","volume":"22","author":"G\u0105ssowska-Dobrowolska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.neuro.2025.103350_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10123031","article-title":"Alterations in cerebellar microtubule cytoskeletal network in a valproicacid-induced rat model of autism spectrum disorders","volume":"10","author":"G\u0105ssowska-Dobrowolska","year":"2022","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.neuro.2025.103350_bib37","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1017\/S1461145712000880","article-title":"Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial","volume":"16","author":"Ghaleiha","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"12","key":"10.1016\/j.neuro.2025.103350_bib38","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.2174\/138161212799958521","article-title":"Basic pharmacology of NMDA receptors","volume":"18","author":"Gonda","year":"2012","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.neuro.2025.103350_bib39","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s41398-020-00904-4","article-title":"Tauopathy in the young autistic brain: novel biomarker and therapeutic target","volume":"10","author":"Grigg","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuro.2025.103350_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175916","article-title":"Risperidone impedes glutamate excitotoxicity in a valproic acid rat model of autism: role of ADAR2 in AMPA GluA2 RNA editing","volume":"955","author":"Habib","year":"2023","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuro.2025.103350_bib41","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41420-023-01362-9","article-title":"NMDARs antagonist MK801 suppresses LPS-induced apoptosis and mitochondrial dysfunction by regulating subunits of NMDARs via the CaM\/CaMKII\/ERK pathway","volume":"9","author":"Han","year":"2023","journal-title":"Cell death Discov."},{"issue":"8","key":"10.1016\/j.neuro.2025.103350_bib42","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1177\/1362361318824103","article-title":"Efficacy and safety of memantine in children with autism spectrum disorder: results from three phase 2 multicenter studies","volume":"23","author":"Hardan","year":"2019","journal-title":"Autism"},{"key":"10.1016\/j.neuro.2025.103350_bib43","article-title":"Memantine nitrate MN-08 suppresses NLRP3 inflammasome activation to protect against sepsis-induced acute lung injury in mice","volume":"156","author":"Hu","year":"2022","journal-title":"Biomed. Pharmacother. = Biomedecine Pharmacother."},{"issue":"19","key":"10.1016\/j.neuro.2025.103350_bib44","doi-asserted-by":"crossref","first-page":"9296","DOI":"10.7150\/thno.60531","article-title":"Upregulated NMDAR-mediated GABAergic transmission underlies autistic-like deficits in Htr3a knockout mice","volume":"11","author":"Huang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.neuro.2025.103350_bib45","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejphar.2017.02.001","article-title":"Memantine reduces the production of amyloid-\u03b2 peptides through modulation of amyloid precursor protein trafficking","volume":"798","author":"Ito","year":"2017","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.neuro.2025.103350_bib46","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/JCP.0000000000000499","article-title":"A prospective open-label trial of memantine hydrochloride for the treatment of social deficits in intellectually capable adults with autism spectrum disorder","volume":"36","author":"Joshi","year":"2016","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuro.2025.103350_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19768354.2014.1003601","article-title":"Combination effect of memantine and mesenchymal stem cells on the recovery of brain damage in a rat model of brain ischemia","volume":"19","author":"Kaengkan","year":"2015","journal-title":"Anim. Cells Syst."},{"key":"10.1016\/j.neuro.2025.103350_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2015.00017","article-title":"Suppression of NMDA receptor function in mice prenatally exposed to valproic acid improves social deficits and repetitive behaviors","volume":"8","author":"Kang","year":"2015","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuro.2025.103350_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109737","article-title":"Memantine: Updating a rare success story in pro-cognitive therapeutics","volume":"244","author":"Karimi Tari","year":"2024","journal-title":"Neuropharmacology"},{"issue":"10","key":"10.1016\/j.neuro.2025.103350_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0292631","article-title":"Possible role of NO\/NMDA pathway in the autistic-like behaviors induced by maternal separation stress in mice","volume":"18","author":"Khaledi","year":"2023","journal-title":"PloS One"},{"issue":"Pt A","key":"10.1016\/j.neuro.2025.103350_bib51","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.neuropharm.2016.09.014","article-title":"Agmatine rescues autistic behaviors in the valproic acid-induced animal model of autism","volume":"113","author":"Kim","year":"2017","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.neuro.2025.103350_bib52","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1159\/000481134","article-title":"Sexually dimorphic epigenetic regulation of brain-derived neurotrophic factor in fetal brain in the valproic acid model of autism spectrum disorder","volume":"39","author":"Konopko","year":"2017","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.neuro.2025.103350_bib53","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.brainresbull.2016.03.013","article-title":"Memantine ameliorates autistic behavior, biochemistry & blood brain barrier impairments in rats","volume":"124","author":"Kumar","year":"2016","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuro.2025.103350_bib54","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.coph.2014.10.007","article-title":"NMDA receptor dysfunction in autism spectrum disorders","volume":"20","author":"Lee","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuro.2025.103350_bib55","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4103\/1673-5374.127012","article-title":"Chronic pre-treatment with memantine prevents amyloid-beta protein-mediated long-term potentiation disruption","volume":"8","author":"Li","year":"2013","journal-title":"Neural Regen. Res."},{"issue":"1","key":"10.1016\/j.neuro.2025.103350_bib56","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12868-021-00647-y","article-title":"Memantine ameliorates cognitive deficit in AD mice via enhancement of entorhinal\u2013CA1 projection","volume":"22","author":"Li","year":"2021","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.neuro.2025.103350_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104918","article-title":"Nuclear factor Kappa B in autism spectrum disorder: a systematic review","volume":"159","author":"Liao","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuro.2025.103350_bib58","article-title":"Oxidative stress in autism spectrum disorder-current progress of mechanisms and biomarkers","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Psychiatry"},{"issue":"4","key":"10.1016\/j.neuro.2025.103350_bib59","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.neuro.2025.103350_bib60","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-025-06834-7","article-title":"Liraglutide improves depressive and cognitive deficits in a high-fat diet rat model of obesity: the role of hippocampal autophagy and the PI3K\/Akt\/mTOR pathway","author":"Magdy","year":"2025","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuro.2025.103350_bib61","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.3389\/fimmu.2020.02021","article-title":"Anti-inflammatory and neuroprotective agents in clinical trials for CNS disease and injury: where do we go from here?","volume":"11","author":"Mallah","year":"2020","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.neuro.2025.103350_bib62","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/mp.2016.95","article-title":"Altered proliferation and networks in neural cells derived from idiopathic autistic individuals","volume":"22","author":"Marchetto","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuro.2025.103350_bib63","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bbi.2019.04.037","article-title":"The influence of neuroinflammation in Autism Spectrum Disorder","volume":"79","author":"Matta","year":"2019","journal-title":"Brain Behav. Immun."},{"issue":"4","key":"10.1016\/j.neuro.2025.103350_bib64","doi-asserted-by":"crossref","first-page":"361","DOI":"10.31887\/DCNS.2016.18.4\/mmccarthy","article-title":"Sex differences in the developing brain as a source of inherent risk","volume":"18","author":"McCarthy","year":"2016","journal-title":"Dialog. Clin. Neurosci."},{"key":"10.1016\/j.neuro.2025.103350_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2020.104901","article-title":"Synaptic elimination by microglia and disturbed higher brain functions","volume":"142","author":"Miyanishi","year":"2021","journal-title":"Neurochem. Int."},{"issue":"1","key":"10.1016\/j.neuro.2025.103350_bib66","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00213-019-05357-2","article-title":"Improvement of autistic-like behaviors in adult rats prenatally exposed to valproic acid through early suppression of NMDA receptor function","volume":"237","author":"Mohammadi","year":"2020","journal-title":"Psychopharmacology"},{"issue":"7","key":"10.1016\/j.neuro.2025.103350_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23073861","article-title":"Autism spectrum disorder: focus on glutamatergic neurotransmission","volume":"23","author":"Montanari","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.neuro.2025.103350_bib68","first-page":"19","article-title":"Comparing efficacy and side effects of memantine vs. risperidone in the treatment of autistic disorder","volume":"50","author":"Nikvarz","year":"2017","journal-title":"Pharmacopsychiatry"},{"issue":"5","key":"10.1016\/j.neuro.2025.103350_bib69","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1038\/s41380-022-01506-w","article-title":"Genetics of glutamate and its receptors in autism spectrum disorder","volume":"27","author":"Nisar","year":"2022","journal-title":"Mol. Psychiatry"},{"issue":"19","key":"10.1016\/j.neuro.2025.103350_bib70","doi-asserted-by":"crossref","DOI":"10.3390\/ijms251910469","article-title":"Animal models of autistic-like behavior in rodents: a scoping review and call for a comprehensive scoring system","volume":"25","author":"Ornoy","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.neuro.2025.103350_bib71","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1089\/cap.2006.16.517","article-title":"A prospective, open-label trial of memantine in the treatment of cognitive, behavioral, and memory dysfunction in pervasive developmental disorders","volume":"16","author":"Owley","year":"2006","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.neuro.2025.103350_bib72","doi-asserted-by":"crossref","first-page":"894","DOI":"10.55730\/1300-0144.5653","article-title":"Effects of thymoquinone and memantine alone and in combination on memory and hippocampal morphology in rats with streptozotocin-induced Alzheimer's disease","volume":"53","author":"\u00d6zsoy","year":"2023","journal-title":"Turk. J. Med. Sci."},{"key":"10.1016\/j.neuro.2025.103350_bib73","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.coph.2015.11.010","article-title":"Novel insights into gliotransmitters","volume":"26","author":"Petrelli","year":"2016","journal-title":"Curr. Opin. Pharmacol."},{"issue":"7","key":"10.1016\/j.neuro.2025.103350_bib74","first-page":"871","article-title":"Chromone derivatives suppress neuroinflammation and improve mitochondrial function in the sporadic form of Alzheimer's disease under experimental conditions","volume":"25","author":"Pozdnyakov","year":"2022","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.neuro.2025.103350_bib75","doi-asserted-by":"crossref","DOI":"10.1038\/srep26052","article-title":"Finding novel distinctions between the sAPP\u03b1-mediated anabolic biochemical pathways in Autism Spectrum Disorder and Fragile X Syndrome plasma and brain tissue","volume":"6","author":"Ray","year":"2016","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.neuro.2025.103350_bib76","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.4103\/1673-5374.332127","article-title":"Amyloid-beta peptide and tau protein crosstalk in Alzheimer's disease","volume":"17","author":"Roda","year":"2022","journal-title":"Neural Regen. Res."},{"issue":"4","key":"10.1016\/j.neuro.2025.103350_bib77","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.neuroscience.2006.08.017","article-title":"Memantine protects against LPS-induced neuroinflammation, restores behaviorally-induced gene expression and spatial learning in the rat","volume":"142","author":"Rosi","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuro.2025.103350_bib78","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bbi.2016.03.009","article-title":"Multiple inflammasome complexes are activated in autistic spectrum disorders","volume":"57","author":"Saresella","year":"2016","journal-title":"Brain Behav. Immun."},{"issue":"6","key":"10.1016\/j.neuro.2025.103350_bib79","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.psyneuen.2008.02.011","article-title":"Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid","volume":"33","author":"Schneider","year":"2008","journal-title":"Psychoneuroendocrinology"},{"issue":"10","key":"10.1016\/j.neuro.2025.103350_bib80","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1021\/acschemneuro.0c00672","article-title":"Inhibition of the ERK1\/2 phosphorylation by dextromethorphan protects against core autistic symptoms in VPA induced autistic rats: in silico and in vivo drug repurposition study","volume":"12","author":"Singla","year":"2021","journal-title":"ACS Chem. Neurosci."},{"issue":"6","key":"10.1016\/j.neuro.2025.103350_bib81","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1177\/08830738060210062201","article-title":"High levels of Alzheimer beta-amyloid precursor protein (APP) in children with severely autistic behavior and aggression","volume":"21","author":"Sokol","year":"2006","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.neuro.2025.103350_bib82","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3389\/fpsyt.2019.00165","article-title":"Novel contribution of secreted amyloid-\u03b2 precursor protein to white matter brain enlargement in autism spectrum disorder","volume":"10","author":"Sokol","year":"2019","journal-title":"Front. Psychiatry"},{"issue":"5","key":"10.1016\/j.neuro.2025.103350_bib83","doi-asserted-by":"crossref","first-page":"7615","DOI":"10.3892\/mmr.2015.4382","article-title":"Anti-autophagic and anti-apoptotic effects of memantine in a SH-SY5Y cell model of Alzheimer's disease via mammalian target of rapamycin-dependent and -independent pathways","volume":"12","author":"Song","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"7","key":"10.1016\/j.neuro.2025.103350_bib84","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1089\/cap.2021.0010","article-title":"Neurocognitive outcomes from memantine: a pilot, double-blind, placebo-controlled trial in children with autism spectrum disorder","volume":"31","author":"Soorya","year":"2021","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"8","key":"10.1016\/j.neuro.2025.103350_bib85","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.neuro.2025.103350_bib86","first-page":"126","article-title":"The effects of memantine on cognitive function and pain after sevoflurane and desflurane anesthesia in streptozotocin induced diabetic rats","volume":"31","author":"Ta\u015f","year":"2020","journal-title":"Gazi Med. J."},{"key":"10.1016\/j.neuro.2025.103350_bib87","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.exer.2019.01.018","article-title":"NLRP3 inflammasome in NMDA-induced retinal excitotoxicity","volume":"181","author":"Tsoka","year":"2019","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.neuro.2025.103350_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2025.111496","article-title":"Disentangling the role of tau pathology in autism spectrum disorders","volume":"142","author":"Villavicencio-Tejo","year":"2025","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.neuro.2025.103350_bib89","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s40478-019-0754-y","article-title":"Intersection of pathological tau and microglia at the synapse","volume":"7","author":"Vogels","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"issue":"5","key":"10.1016\/j.neuro.2025.103350_bib90","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035414","article-title":"Abnormal intracellular accumulation and extracellular A\u03b2 deposition in idiopathic and Dup15q11.2-q13 autism spectrum disorders","volume":"7","author":"Wegiel","year":"2012","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.neuro.2025.103350_bib91","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25010432","article-title":"Exogenous IL-17A alleviates social behavior deficits and increases neurogenesis in a murine model of autism spectrum disorders","volume":"25","author":"Willinger","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuro.2025.103350_bib92","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.634837","article-title":"Critical role of TLR4 on the microglia activation induced by maternal LPS exposure leading to ASD-like behavior of offspring","volume":"9","author":"Xiao","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.neuro.2025.103350_bib93","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1125428","article-title":"Microglia and astrocytes underlie neuroinflammation and synaptic susceptibility in autism spectrum disorder","volume":"17","author":"Xiong","year":"2023","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.neuro.2025.103350_bib94","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/s41380-021-01092-3","article-title":"Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications","volume":"27","author":"Yan","year":"2022","journal-title":"Mol. Psychiatry"},{"issue":"21","key":"10.1016\/j.neuro.2025.103350_bib95","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111516","article-title":"The role of maternal immune activation in the pathogenesis of autism: a review of the evidence, proposed mechanisms and implications for treatment","volume":"22","author":"Zawadzka","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.neuro.2025.103350_bib96","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/jnen\/nlab132","article-title":"Acupuncture at ST36 alleviates the behavioral disorder of autistic rats by inhibiting TXNIP-mediated activation of NLRP3","volume":"81","author":"Zhao","year":"2022","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"2","key":"10.1016\/j.neuro.2025.103350_bib97","first-page":"464","article-title":"Memantine\/aripiprazole combination alleviates cognitive dysfunction in valproic acid rat model of autism: hippocampal CREB\/BDNF signaling and glutamate homeostasis","volume":"20","author":"Zohny","year":"2023","journal-title":"Neurother. J. Am. Soc. Exp. Neurother."}],"container-title":["NeuroToxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X25001561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X25001561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T08:46:11Z","timestamp":1781167571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161813X25001561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":97,"alternative-id":["S0161813X25001561"],"URL":"https:\/\/doi.org\/10.1016\/j.neuro.2025.103350","relation":{},"ISSN":["0161-813X"],"issn-type":[{"value":"0161-813X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blockade of NMDA-receptors mitigates autistic and cognitive behaviors via modulation of TLR-4\/NLRP3 inflammasomes and microglia\/astrocyte crosstalk in rat model of autism","name":"articletitle","label":"Article Title"},{"value":"NeuroToxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuro.2025.103350","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103350"}}